TY  - GEN
AU  - Lim,Jonathan
AU  - Samuelsen,Carl
AU  - Golembesky,Amanda
AU  - Shrestha,Sulena
AU  - Wang,Li
AU  - Griebsch,Ingolf
TI  - Duration of treatment among patients prescribed afatinib or erlotinib as first-line therapy for EGFR mutation-positive non-small-cell lung cancer in the USA
SN  - 1744-8301
PY  - 2019///0909
KW  - Adolescent
KW  - Adult
KW  - Afatinib
KW  - therapeutic use
KW  - Aged
KW  - Carcinoma, Non-Small-Cell Lung
KW  - drug therapy
KW  - ErbB Receptors
KW  - antagonists & inhibitors
KW  - Erlotinib Hydrochloride
KW  - Female
KW  - Follow-Up Studies
KW  - Humans
KW  - Lung Neoplasms
KW  - Male
KW  - Middle Aged
KW  - Mutation
KW  - Prognosis
KW  - Protein Kinase Inhibitors
KW  - Retrospective Studies
KW  - Survival Rate
KW  - Time Factors
KW  - Young Adult
N1  - Publication Type: Comparative Study; Journal Article
UR  - https://doi.org/10.2217/fon-2019-0052
ER  -